Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 12/2017

03.02.2017 | Original Paper

Neighborhood Characteristics Associated with Achievement and Maintenance of HIV Viral Suppression Among Persons Newly Diagnosed with HIV in New York City

verfasst von: Ellen W. Wiewel, Luisa N. Borrell, Heidi E. Jones, Andrew R. Maroko, Lucia V. Torian

Erschienen in: AIDS and Behavior | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

We investigated the effect of neighborhood characteristics on achievement and maintenance of HIV viral suppression among New York City (NYC) residents aged 13 years and older diagnosed between 2006 and 2012. Individual records from the NYC HIV surveillance registry (n = 12,547) were linked to U.S. Census and American Community Survey data by census tract of residence. Multivariable proportional hazards regression models indicated the likelihood of achievement and maintenance of suppression by neighborhood characteristics including poverty, accounting for neighborhood clustering and for individual characteristics. In adjusted analyses, no neighborhood factors were associated with achievement of suppression. However, residents of high- or very-high-poverty neighborhoods were less likely than residents of low-poverty neighborhoods to maintain suppression. In conclusion, higher neighborhood poverty was associated with lesser maintenance of suppression. Assistance with post-diagnosis retention in care, antiretroviral therapy prescribing, or adherence targeted to residents of higher-poverty neighborhoods may improve maintenance of viral suppression in NYC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Kaplan JE, et al. Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents. AIDS. 2001;15(14):1831–6.CrossRefPubMed
2.
Attia S, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23(11):1397–404.CrossRefPubMed
3.
The White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States. Washington, DC; July 2010.
4.
Gardner EM, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.CrossRefPubMedPubMedCentral
5.
Moore RD, Bartlett JG. Dramatic decline in the HIV-1 RNA level over calendar time in a large urban HIV practice. Clin Infect Dis. 2011;53(6):600–4.CrossRefPubMedPubMedCentral
6.
Novak RM, et al. Disparities in initiation of combination antiretroviral treatment and in virologic suppression among patients in the HIV Outpatient Study (HOPS), 2000–2013. J Acquir Immune Defic Syndr. 2015;70:23–32.CrossRefPubMed
7.
Centers for Disease Control and Prevention. Vital signs: HIV prevention through care and treatment–United States. MMWR Morb Mortal Wkly Rep. 2011;60(47):1618–23.
8.
Torian LV, Xia Q, Wiewel EW. Retention in care and viral suppression among persons living with HIV/AIDS in New York City, 2006–2010. Am J Public Health. 2014;104(9):e24–9.CrossRefPubMedPubMedCentral
9.
Wiewel EW, et al. Monitoring outcomes for newly diagnosed and prevalent HIV cases using a care continuum created with New York City surveillance data. JAIDS J Acquir Immune Defic Syndr. 2015;68(2):217–26.CrossRefPubMed
10.
11.
Torian LV, Xia Q. Achievement and maintenance of viral suppression in persons newly diagnosed with HIV, New York City, 2006–2009: using population surveillance data to measure the treatment part of “test and treat”. J Acquir Immune Defic Syndr. 2013;63(3):379–86.CrossRefPubMed
12.
Soon GG, et al. Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000–2008). AIDS Patient Care STDS. 2012;26(8):444–53.CrossRefPubMed
13.
Benbow N, et al. Linkage, retention, ART use and viral suppression in four large cities in the United States. In: International AIDS Conference, Washington, DC; 2012.
14.
Valdez H, et al. Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcome. Arch Intern Med. 1999;159(15):1771–6.CrossRefPubMed
15.
Beer L, et al. Racial disparities in antiretroviral therapy use and viral suppression among sexually active HIV-infected men who have sex with men—United States, Medical Monitoring Project, 2009. In: International AIDS Conference, July 23, Washington, DC; 2012.
16.
Dombrowski JC, et al. Population-based metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression. AIDS. 2012;26(1):77–86.CrossRefPubMedPubMedCentral
17.
Shacham E, et al. The interplay of sociodemographic factors on virologic suppression among a U.S. outpatient HIV clinic population. AIDS Patient Care STDS. 2010;24(4):229–35.CrossRefPubMedPubMedCentral
18.
Weintrob AC, et al. Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care. J Acquir Immune Defic Syndr. 2009;52(5):574–80.CrossRefPubMed
19.
Millett GA, et al. Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis. Lancet. 2012;380(9839):341–8.CrossRefPubMed
20.
Phillips AN, et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA. 2001;286(20):2560–7.CrossRefPubMed
21.
Paredes R, et al. Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Arch Intern Med. 2000;160(8):1123–32.CrossRefPubMed
22.
Xia Q, et al. Comparison of indicators measuring the proportion of human immunodeficiency virus-infected persons with a suppressed viral load. Ann Epidemiol. 2015;25:226–30.CrossRefPubMed
23.
Joy R, et al. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr. 2008;47(4):500–5.CrossRefPubMed
24.
Wood E, et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS. 2002;16(15):2065–72.CrossRefPubMed
25.
Ickovics JR, Meade CS. Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S98–102.CrossRefPubMed
26.
Kitahata MM, Van Rompaey SE, Shields AW. Physician experience in the care of HIV-infected persons is associated with earlier adoption of new antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;24(2):106–14.CrossRefPubMed
27.
Wiewel EW, et al. The association between area-based poverty and HIV diagnoses: findings from New York City. Public Health Rep. 2016;131(2):290–302.CrossRefPubMedPubMedCentral
28.
Gant Z, et al. A county-level examination of the relationship between HIV and social determinants of health: 40 states, 2006–2008. Open AIDS J. 2012;6:1–7.CrossRef
29.
Song R, et al. Identifying the impact of social determinants of health on disease rates using correlation analysis of area-based summary information. Public Health Rep. 2011;126(Suppl 3):70–80.CrossRefPubMedPubMedCentral
30.
Lopez-De Fede A, et al. Spatial visualization of multivariate datasets: an analysis of STD and HIV/AIDS diagnosis rates and socioeconomic context using ring maps. Public Health Rep. 2011;126(Suppl 3):115–26.CrossRefPubMedPubMedCentral
31.
An Q, et al. Association between community socioeconomic position and HIV diagnosis rate among adults and adolescents in the United States, 2005 to 2009. Am J Public Health. 2013;103(1):120–6.CrossRefPubMedPubMedCentral
32.
Shacham E, et al. Are neighborhood conditions associated with HIV management? HIV Med. 2013;14(10):624–32.CrossRefPubMed
33.
Yen IH, Kaplan GA. Neighborhood social environment and risk of death: multilevel evidence from the Alameda County Study. Am J Epidemiol. 1999;149(10):898–907.CrossRefPubMed
34.
Lazar R, et al. Neighborhood poverty and infectious diseases: health disparities in New York City. New York City Department of Health and Mental Hygiene: Epi Data Brief; 2016. p. 1–3.
35.
Terzian AS, et al. Novel use of surveillance data to detect HIV-infected persons with sustained high viral load and durable virologic suppression in New York City. PLoS ONE. 2012;7(1):e29679.CrossRefPubMedPubMedCentral
36.
Stadelmann L, et al. Changes in HIV viral load suppression among HIV + New Yorkers, 2006–2007 to 2010–2011. In: Conference on Retroviruses and Opportunistic Infections, Atlanta; 2013.
37.
Beer L, et al. Disparities in HIV transmission risk among HIV-infected black and white men who have sex with men, United States, 2009. AIDS. 2014;28(1):105–14.CrossRefPubMedPubMedCentral
38.
39.
40.
41.
Gordon D. Relative frequency of different below-limit VL ranges over time, S.L. Braunstein, Editor; 2011.
42.
Cozzi-Lepri A, et al. Changes in viral load in people with virological failure who remain on the same HAART regimen. Antivir Ther. 2003;8(2):127–36.PubMed
43.
Quinn TC, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342(13):921–9.CrossRefPubMed
44.
Panel on Antiretroviral Guidelines for Adults and Adolescents, Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. December 1, 2009, Department of Health and Human Services.
45.
Xia Q, et al. Proportions of patients with HIV retained in care and virally suppressed in New York City and the United States: higher than we thought. J Acquir Immune Defic Syndr. 2015;68(3):351–8.CrossRefPubMed
46.
Krieger N, et al. Monitoring socioeconomic inequalities in sexually transmitted infections, tuberculosis, and violence: geocoding and choice of area-based socioeconomic measures–the public health disparities geocoding project (US). Public Health Rep. 2003;118(3):240–60.CrossRefPubMedPubMedCentral
47.
48.
Toprani, A, Hadler J. Selecting and applying a standard area-based socioeconomic status measure for public health data: analysis for New York City, in Epi Research Report, New York City Department of Health and Mental Hygiene; 2013, pp. 1–12.
49.
Panel on Clinical Practices for Treatment of HIV Infection, Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 7 April 2005, Department of Health and Human Services.
50.
Panel on Antiretroviral Guidelines for Adults and Adolescents, Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 1 December 2007, Department of Health and Human Services.
51.
Lee EW, Wei LJ, Amato DA. Cox-type regression analysis for large numbers of small groups of correlated failure time observations. In: Klein JP, Goel PK, editors. Survival analysis: state of the art. Dordrecht: Kluwer Academic Publishers; 1992.
52.
Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc. 1989;84(408):1074–8.CrossRef
53.
54.
Eberhart MG, et al. Individual and community factors associated with geographic clusters of poor HIV care retention and poor viral suppression. JAIDS J Acquir Immune Defic Syndr. 2015;69:S37–43.CrossRefPubMed
55.
Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA. 1990;263(10):1385–9.CrossRefPubMed
56.
Dwan K, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias—an updated review. PLoS ONE. 2013;8(7):e66844.CrossRefPubMedPubMedCentral
57.
58.
New York State Office of the Governor. Governor Cuomo announces all HIV-positive individuals in New York City to become eligible for housing, transportation and nutritional support. NY: Albany; 2016.
59.
60.
Hanna D, Weglein D, Begier E. Increase in out-migration in persons reported with AIDS in New York City since the introduction of HAART. In: XVII International AIDS Conference, Mexico City, Mexico; 2008.
61.
62.
HIV Epidemiology and Field Services Program, Medical care and clinical status among persons with HIV in New York, 2014. New York City: New York City Department of Health and Mental Hygiene; 2015.
63.
Chander G, et al. HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use. AIDS Care. 2009;21(5):655–63.CrossRefPubMedPubMedCentral
64.
Westergaard RP, Spaulding AC, Flanigan TP. HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis. 2013;26(1):10–6.CrossRefPubMedPubMedCentral
65.
66.
67.
Fotheringham AS, Wong DWS. The modifiable areal unit problem in multivariate statistical analysis. Environ Plan A. 1991;23(7):1024–44.CrossRef
68.
Openshaw S. The modifiable areal unit problem. Concepts Tech Mod Geogr. 1983;38:41.
69.
O’Sullivan D, Wong DWS. A surface-based approach to measuring spatial segregation. Geogr Anal. 2007;39:147–68.CrossRef
70.
Griffith D. Towards a theory of spatial statistics. Geogr Anal. 1980;12:325–39.CrossRef
71.
Griffith DA. The boundary value problem in spatial statistical analysis. J Reg Sci. 1983;23(3):377–87.CrossRefPubMed
72.
Torian LV, et al. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med. 2008;168(11):1181–7.CrossRefPubMed
73.
Torian LV, Wiewel EW. Continuity of HIV-related medical care, New York City, 2005–2009: Do patients who initiate care stay in care? AIDS Patient Care STDS. 2011;25(2):79–88.CrossRefPubMed
Metadaten
Titel
Neighborhood Characteristics Associated with Achievement and Maintenance of HIV Viral Suppression Among Persons Newly Diagnosed with HIV in New York City
verfasst von
Ellen W. Wiewel
Luisa N. Borrell
Heidi E. Jones
Andrew R. Maroko
Lucia V. Torian
Publikationsdatum
03.02.2017
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 12/2017
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1700-2

Weitere Artikel der Ausgabe 12/2017

AIDS and Behavior 12/2017 Zur Ausgabe

Original Paper

Acceptability of Daily Use of Free Oral Pre-exposure Prophylaxis (PrEP) Among Transgender Women Sex Workers in Shenyang, China

Original Paper

Caregivers’ Support Network Characteristics Associated with Viral Suppression among HIV Care Recipients

Original Paper

Can Burt’s Theory of Structural Holes be Applied to Study Social Support Among Mid-Age Female Sex Workers? A Multi-Site Egocentric Network Study in China

Original Paper

Perceived Barriers and Facilitators to Integrating HIV Prevention and Treatment with Cross-Sex Hormone Therapy for Transgender Women in Lima, Peru

OriginalPaper

Punto Seguro: A Randomized Controlled Pilot Using Conditional Economic Incentives to Reduce Sexually Transmitted Infection Risks in Mexico

Original Paper

The Where and How for Reaching Transgender Women and Men Who Have Sex with Men with HIV Prevention Services in Guatemala

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 | NSCLC | Nachrichten

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise